Can-Fite BioPharma (CANF) Shares Outstanding (Diluted) (2020 - 2026)
Can-Fite BioPharma (CANF) posted Shares Outstanding (Diluted) of 823,104 for Q2 2026, down 98.5% from 54.4 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Since Q4 2020, Can-Fite BioPharma has reported Shares Outstanding (Diluted) for 18 quarters.
- Annual Shares Outstanding (Diluted) shows a five-year compound annual growth rate of -38.0% (FY2020 to FY2025).
- In prior years, Can-Fite BioPharma's Shares Outstanding (Diluted) was 54.4 million in FY2024 (+70.2%), 31.96 million in FY2023 (+56.7%), 20.39 million in FY2022 (+47.5%) and 13.83 million in FY2021 (+54.3%).
- Quarterly Shares Outstanding (Diluted) has run from a low of 823,104 in Q4 2025 to a high of 54.4 million in Q2 2025 over five years.
- On a year-over-year basis, Shares Outstanding (Diluted) increased in two of the last four quarters, with an average decline of 14.1%.
- The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q2 2025, with growth of 70.2%; the weakest was Q4 2025, with a decline of 98.5%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 823,104.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 823,104.00 |
| Dec 31, 2025 | 823,104.00 |
| Jun 30, 2025 | 54.40 Mn |
| Dec 31, 2024 | 54.40 Mn |
| Jun 30, 2024 | 31.96 Mn |
| Dec 31, 2023 | 31.96 Mn |
| Sep 30, 2023 | 20.39 Mn |
| Jun 30, 2023 | 20.39 Mn |
| Mar 31, 2023 | 20.39 Mn |
| Dec 31, 2022 | 20.39 Mn |
| Sep 30, 2022 | 13.83 Mn |
| Jun 30, 2022 | 13.83 Mn |
| Mar 31, 2022 | 13.83 Mn |
| Dec 31, 2021 | 13.83 Mn |
| Sep 30, 2021 | 8.96 Mn |
| Jun 30, 2021 | 8.96 Mn |
| Mar 31, 2021 | 8.96 Mn |
| Dec 31, 2020 | 8.96 Mn |
API Access
Can-Fite BioPharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();